Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adolescent Behavior | 13 | 2024 | 270 | 3.560 |
Why?
|
| Substance-Related Disorders | 18 | 2024 | 825 | 3.090 |
Why?
|
| Receptors, GABA-A | 7 | 2019 | 65 | 2.720 |
Why?
|
| Parenting | 7 | 2024 | 135 | 2.580 |
Why?
|
| Alcoholism | 16 | 2024 | 292 | 2.190 |
Why?
|
| Adolescent | 43 | 2024 | 5950 | 2.120 |
Why?
|
| Peer Group | 9 | 2023 | 173 | 1.950 |
Why?
|
| Juvenile Delinquency | 8 | 2021 | 44 | 1.820 |
Why?
|
| Alcohol Drinking | 12 | 2024 | 585 | 1.480 |
Why?
|
| Longitudinal Studies | 21 | 2024 | 1020 | 1.320 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2022 | 727 | 1.320 |
Why?
|
| Child | 26 | 2024 | 3381 | 1.310 |
Why?
|
| Male | 47 | 2024 | 22779 | 1.070 |
Why?
|
| Female | 47 | 2024 | 24018 | 1.030 |
Why?
|
| Depression | 8 | 2024 | 837 | 1.000 |
Why?
|
| Humans | 64 | 2024 | 42163 | 1.000 |
Why?
|
| Aggression | 6 | 2020 | 101 | 0.960 |
Why?
|
| Temperament | 4 | 2021 | 36 | 0.940 |
Why?
|
| Genotype | 6 | 2021 | 796 | 0.890 |
Why?
|
| Child Abuse | 2 | 2023 | 90 | 0.880 |
Why?
|
| Marijuana Smoking | 3 | 2023 | 90 | 0.860 |
Why?
|
| Cannabis | 2 | 2023 | 90 | 0.860 |
Why?
|
| Anxiety | 6 | 2024 | 847 | 0.840 |
Why?
|
| Mother-Child Relations | 1 | 2024 | 61 | 0.830 |
Why?
|
| Goals | 2 | 2013 | 33 | 0.770 |
Why?
|
| Acculturation | 1 | 2024 | 203 | 0.770 |
Why?
|
| Emotions | 7 | 2022 | 251 | 0.760 |
Why?
|
| Risk Factors | 15 | 2022 | 3942 | 0.670 |
Why?
|
| Marijuana Abuse | 4 | 2018 | 93 | 0.670 |
Why?
|
| Internal-External Control | 3 | 2019 | 60 | 0.660 |
Why?
|
| Prospective Studies | 10 | 2024 | 1574 | 0.650 |
Why?
|
| Self Concept | 2 | 2013 | 170 | 0.620 |
Why?
|
| Negotiating | 1 | 2018 | 26 | 0.560 |
Why?
|
| Interpersonal Relations | 3 | 2017 | 216 | 0.530 |
Why?
|
| Social Behavior Disorders | 1 | 2016 | 5 | 0.490 |
Why?
|
| Attitude to Health | 1 | 2018 | 336 | 0.490 |
Why?
|
| Parents | 5 | 2023 | 359 | 0.470 |
Why?
|
| Self Efficacy | 3 | 2024 | 211 | 0.460 |
Why?
|
| Adolescent Development | 2 | 2018 | 39 | 0.440 |
Why?
|
| Tobacco Use Disorder | 1 | 2017 | 249 | 0.430 |
Why?
|
| Personality Development | 1 | 2013 | 8 | 0.420 |
Why?
|
| Affective Symptoms | 4 | 2022 | 60 | 0.420 |
Why?
|
| Parent-Child Relations | 3 | 2024 | 125 | 0.410 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 3 | 2017 | 15 | 0.390 |
Why?
|
| Alleles | 3 | 2019 | 352 | 0.380 |
Why?
|
| Reproducibility of Results | 5 | 2022 | 1058 | 0.380 |
Why?
|
| Brain | 3 | 2022 | 1452 | 0.370 |
Why?
|
| Adult | 16 | 2024 | 13458 | 0.360 |
Why?
|
| Personality Assessment | 1 | 2011 | 44 | 0.360 |
Why?
|
| Social Adjustment | 1 | 2011 | 30 | 0.360 |
Why?
|
| Young Adult | 12 | 2024 | 4936 | 0.350 |
Why?
|
| Michigan | 4 | 2020 | 52 | 0.340 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2016 | 860 | 0.340 |
Why?
|
| Child, Preschool | 4 | 2024 | 1516 | 0.330 |
Why?
|
| Conduct Disorder | 2 | 2021 | 54 | 0.320 |
Why?
|
| Theory of Mind | 2 | 2020 | 4 | 0.310 |
Why?
|
| Receptors, Dopamine D4 | 2 | 2021 | 16 | 0.310 |
Why?
|
| Psychometrics | 1 | 2011 | 350 | 0.300 |
Why?
|
| Students | 2 | 2024 | 617 | 0.280 |
Why?
|
| Asthma | 2 | 2021 | 410 | 0.260 |
Why?
|
| Cross-Sectional Studies | 4 | 2022 | 3077 | 0.250 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2019 | 297 | 0.230 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2022 | 577 | 0.230 |
Why?
|
| Impulsive Behavior | 3 | 2021 | 54 | 0.230 |
Why?
|
| Attitude | 2 | 2018 | 108 | 0.220 |
Why?
|
| Residence Characteristics | 2 | 2020 | 359 | 0.220 |
Why?
|
| Ethanol | 2 | 2023 | 221 | 0.210 |
Why?
|
| Models, Psychological | 2 | 2016 | 141 | 0.200 |
Why?
|
| Social Isolation | 1 | 2023 | 34 | 0.200 |
Why?
|
| Alcohol-Related Disorders | 2 | 2018 | 63 | 0.200 |
Why?
|
| Quality of Life | 3 | 2022 | 599 | 0.190 |
Why?
|
| Interviews as Topic | 1 | 2024 | 428 | 0.190 |
Why?
|
| New York | 2 | 2014 | 88 | 0.190 |
Why?
|
| Pilot Projects | 2 | 2024 | 733 | 0.190 |
Why?
|
| Sleep | 1 | 2024 | 179 | 0.190 |
Why?
|
| Anxiety Disorders | 3 | 2022 | 319 | 0.190 |
Why?
|
| Factor Analysis, Statistical | 2 | 2021 | 157 | 0.180 |
Why?
|
| Rhinitis | 1 | 2021 | 17 | 0.180 |
Why?
|
| Intention | 1 | 2022 | 103 | 0.180 |
Why?
|
| Mothers | 1 | 2024 | 212 | 0.180 |
Why?
|
| Risk | 3 | 2020 | 289 | 0.180 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2022 | 70 | 0.170 |
Why?
|
| Preventive Medicine | 1 | 2021 | 16 | 0.170 |
Why?
|
| Awareness | 1 | 2021 | 73 | 0.170 |
Why?
|
| Binge-Eating Disorder | 1 | 2020 | 8 | 0.170 |
Why?
|
| Models, Genetic | 2 | 2018 | 181 | 0.170 |
Why?
|
| Genome-Wide Association Study | 2 | 2022 | 421 | 0.160 |
Why?
|
| Commerce | 1 | 2021 | 95 | 0.160 |
Why?
|
| Gyrus Cinguli | 1 | 2019 | 30 | 0.160 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 2 | 2021 | 55 | 0.150 |
Why?
|
| Family | 1 | 2020 | 192 | 0.150 |
Why?
|
| Registries | 1 | 2021 | 431 | 0.150 |
Why?
|
| Gender Identity | 2 | 2011 | 117 | 0.150 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2018 | 21 | 0.140 |
Why?
|
| Defense Mechanisms | 1 | 2018 | 10 | 0.140 |
Why?
|
| Monte Carlo Method | 1 | 2018 | 66 | 0.140 |
Why?
|
| Schools | 1 | 2020 | 283 | 0.140 |
Why?
|
| Mental Health | 1 | 2022 | 363 | 0.140 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 309 | 0.140 |
Why?
|
| Neuropeptide Y | 1 | 2017 | 26 | 0.140 |
Why?
|
| Smoking | 3 | 2020 | 1019 | 0.140 |
Why?
|
| Inpatients | 2 | 2018 | 78 | 0.140 |
Why?
|
| Substance Abuse Detection | 2 | 2008 | 31 | 0.130 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2017 | 81 | 0.130 |
Why?
|
| Depressive Disorder | 1 | 2018 | 185 | 0.130 |
Why?
|
| Resilience, Psychological | 1 | 2017 | 89 | 0.130 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 1 | 2016 | 4 | 0.120 |
Why?
|
| Arousal | 1 | 2016 | 95 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 2017 | 318 | 0.120 |
Why?
|
| Nucleus Accumbens | 1 | 2016 | 99 | 0.120 |
Why?
|
| Reward | 1 | 2016 | 106 | 0.120 |
Why?
|
| Socialization | 1 | 2015 | 20 | 0.120 |
Why?
|
| Models, Statistical | 2 | 2018 | 190 | 0.110 |
Why?
|
| Heterozygote | 1 | 2015 | 107 | 0.110 |
Why?
|
| Treatment Outcome | 4 | 2019 | 1586 | 0.110 |
Why?
|
| Poverty Areas | 1 | 2014 | 46 | 0.110 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2014 | 26 | 0.110 |
Why?
|
| Social Control, Informal | 1 | 2013 | 10 | 0.100 |
Why?
|
| Child Behavior Disorders | 1 | 2013 | 35 | 0.100 |
Why?
|
| Prefrontal Cortex | 1 | 2014 | 160 | 0.090 |
Why?
|
| Social Behavior | 1 | 2013 | 160 | 0.090 |
Why?
|
| Psychotherapy, Group | 2 | 2014 | 23 | 0.090 |
Why?
|
| Character | 1 | 2011 | 2 | 0.090 |
Why?
|
| Hierarchy, Social | 1 | 2011 | 9 | 0.090 |
Why?
|
| Life Style | 1 | 2013 | 326 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2014 | 429 | 0.090 |
Why?
|
| Principal Component Analysis | 1 | 2011 | 87 | 0.090 |
Why?
|
| Amygdala | 2 | 2022 | 125 | 0.090 |
Why?
|
| Social Identification | 1 | 2011 | 63 | 0.090 |
Why?
|
| Cerebral Cortex | 2 | 2022 | 303 | 0.080 |
Why?
|
| Age Factors | 1 | 2013 | 1139 | 0.080 |
Why?
|
| Neoplasms | 1 | 2021 | 1341 | 0.080 |
Why?
|
| Middle Aged | 6 | 2024 | 11819 | 0.080 |
Why?
|
| Prevalence | 2 | 2020 | 1597 | 0.080 |
Why?
|
| Motivation | 1 | 2013 | 492 | 0.080 |
Why?
|
| Linkage Disequilibrium | 2 | 2022 | 85 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2024 | 708 | 0.070 |
Why?
|
| Deception | 1 | 2007 | 7 | 0.070 |
Why?
|
| Counseling | 1 | 2007 | 134 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2018 | 1266 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2014 | 280 | 0.050 |
Why?
|
| Hospitalization | 1 | 2007 | 482 | 0.050 |
Why?
|
| Florida | 1 | 2024 | 461 | 0.050 |
Why?
|
| Multifactorial Inheritance | 1 | 2022 | 32 | 0.050 |
Why?
|
| United States | 3 | 2020 | 5072 | 0.050 |
Why?
|
| Empathy | 1 | 2021 | 31 | 0.040 |
Why?
|
| Disease Management | 1 | 2021 | 68 | 0.040 |
Why?
|
| Behavior, Addictive | 1 | 2021 | 37 | 0.040 |
Why?
|
| Taxes | 1 | 2021 | 14 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2021 | 61 | 0.040 |
Why?
|
| Data Collection | 1 | 2021 | 210 | 0.040 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2021 | 45 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2021 | 62 | 0.040 |
Why?
|
| Sweden | 1 | 2020 | 17 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2021 | 200 | 0.040 |
Why?
|
| Pain Threshold | 1 | 2020 | 34 | 0.040 |
Why?
|
| Universities | 1 | 2024 | 539 | 0.040 |
Why?
|
| Exploratory Behavior | 1 | 2020 | 78 | 0.040 |
Why?
|
| Canada | 1 | 2020 | 157 | 0.040 |
Why?
|
| Attention | 1 | 2021 | 165 | 0.040 |
Why?
|
| Health Policy | 1 | 2021 | 184 | 0.040 |
Why?
|
| Validation Studies as Topic | 1 | 2018 | 8 | 0.040 |
Why?
|
| Emotional Intelligence | 1 | 2017 | 8 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 1054 | 0.030 |
Why?
|
| Public Health | 1 | 2021 | 405 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2018 | 404 | 0.030 |
Why?
|
| Sex Factors | 1 | 2018 | 1008 | 0.030 |
Why?
|
| Risk-Taking | 1 | 2018 | 456 | 0.030 |
Why?
|
| Negativism | 1 | 2014 | 3 | 0.030 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2014 | 44 | 0.030 |
Why?
|
| Haplotypes | 1 | 2014 | 197 | 0.030 |
Why?
|
| Sex Offenses | 1 | 2014 | 43 | 0.030 |
Why?
|
| Mass Screening | 1 | 2018 | 531 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2020 | 2485 | 0.030 |
Why?
|
| Linear Models | 1 | 2014 | 311 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2014 | 225 | 0.020 |
Why?
|
| Educational Status | 1 | 2014 | 335 | 0.020 |
Why?
|
| Social Support | 1 | 2014 | 438 | 0.020 |
Why?
|
| Comorbidity | 1 | 2013 | 725 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2014 | 641 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2007 | 10 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2007 | 47 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2007 | 57 | 0.020 |
Why?
|
| Immunoassay | 1 | 2007 | 69 | 0.020 |
Why?
|
| Cocaine-Related Disorders | 1 | 2007 | 99 | 0.020 |
Why?
|
| Central Nervous System Stimulants | 1 | 2007 | 181 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 1051 | 0.010 |
Why?
|
| Aged | 1 | 2007 | 7982 | 0.010 |
Why?
|